Cautious FDA Is Obstacle For Burgeoning Diabetes Device Market

Is innovation in the diabetes device market being hampered by a slowdown in FDA approvals? That question was the unofficial, under-riding theme at the American Diabetes Association 71st Scientific Sessions in June.

More from Archive

More from Medtech Insight